Data / Research funding / California / Rejuvenation Technologies, Inc.
Rejuvenation Technologies, Inc.: 4 NIH awards ($4.2M), fiscal years 2021 to 2026
Rejuvenation Technologies, Inc. in Mountain View, CA is funded under 4 NIH awards ($4.2M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- T6RGDB42JZN6
- State
- California
Awards
4 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $2,484,849 | September 10, 2020 | August 31, 2025 | RAMUNAS, JOHN | reporter.nih.gov |
| Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic | NIH | National Center for Advancing Translational Sciences | 2024 | $1,084,194 | August 1, 2024 | May 31, 2026 | RAMUNAS, JOHN | reporter.nih.gov |
| Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells | NIH | National Institute of General Medical Sciences | 2024 | $324,998 | September 15, 2024 | September 14, 2025 | RAMUNAS, JOHN | reporter.nih.gov |
| TERT mRNA lipid nanoparticles to extend telomeres to treat pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 | $299,987 | September 25, 2022 | July 31, 2023 | RAMUNAS, JOHN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2024 | 3 | $3,267,298 | 0 | $0 |
| 2023 | 1 | $626,743 | 0 | $0 |
| 2022 | 1 | $299,987 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.859 | November 10, 2026 | Not listed | Same assistance listing 93.859 as 1 award here |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | PAR-25-158 | NIH | 93.273 | November 17, 2026 | Not listed | Same assistance listing 93.273 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.273 | November 23, 2026 | $375,000 | Same assistance listing 93.273 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.273 | November 24, 2026 | Not listed | Same assistance listing 93.273 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.838 | December 4, 2026 | Not listed | Same assistance listing 93.838 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.838 | January 7, 2027 | $375,000 | Same assistance listing 93.838 as 1 award here |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | PAR-25-159 | NIH | 93.273 | January 7, 2027 | Not listed | Same assistance listing 93.273 as 1 award here |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) | PAR-25-221 | NIH | 93.273 | January 7, 2027 | Not listed | Same assistance listing 93.273 as 1 award here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.273 | January 7, 2027 | Not listed | Same assistance listing 93.273 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.838 | January 7, 2027 | Not listed | Same assistance listing 93.838 as 1 award here |
| NIH Specialized Center Grant (Parent P50) | PA-28-011 | NIH | 93.273 | January 11, 2027 | Not listed | Same assistance listing 93.273 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.273 | January 15, 2027 | $350,000 | Same assistance listing 93.273 as 1 award here |
| Medical Scientist Training Program (MSTP) (T32) | PAR-24-128 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32) | PAR-24-235 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34) | PAR-24-236 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 1 award here |
| Clinical and Translational Science Award | PAR-28-002 | NIH | 93.350 | January 25, 2027 | Not listed | Same assistance listing 93.350 as 1 award here |
Topics of its NIH awards
- Bioengineering
- Genetics
- Nanotechnology
- Lung
- Pulmonary Fibrosis
- Stem Cell Research
- Stem Cell Research - Nonembryonic - Non-Human
- Chronic Liver Disease and Cirrhosis
- Digestive Diseases
- Liver Disease
- Autoimmune Disease
- Orphan Drug
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.